Access to National Healthcare Systems: The Deadline for Action Is Getting Closer

Key Takeaways

• NHS England ends CIS1 support by Feb 2027.
• Trusts must migrate to CIS2 for high‑assurance authentication.
• Imprivata offers EAM and Virtual Smartcards for seamless transition.
• Dual clinician identities complicate workflow across local and national systems.
• New EU NIS2 and UK CAF regulations tighten security requirements.

Pulse Analysis

The transition from CIS1 to CIS2 reflects a broader shift in national health IT toward open standards and high‑assurance authentication. CIS1, built on legacy PKI smartcards, is being phased out as cyber‑criminal activity intensifies and regulators demand stronger identity proofing. By 28 February 2027, trusts that have not migrated will lose access to critical services such as the NHS Spine, jeopardising clinical workflows and exposing patient records to heightened risk.

Clinicians in the UK and Europe routinely juggle two separate identities—one for local hospital systems and another for national platforms—creating friction and increasing the likelihood of errors. High‑assurance multi‑factor solutions must work on shared devices, support roaming workstations, and integrate seamlessly with electronic patient record (EPR) applications. Imprivata’s Enterprise Access Management (EAM) addresses these constraints by offering virtual smartcards, proximity badges, facial recognition, and hands‑free authentication that align with both CIS1 legacy and emerging CIS2 requirements, preserving a "no‑click" experience for clinicians.

Strategically, early adoption of CIS2 and related security frameworks such as the EU NIS2 directive and the UK Cyber Assessment Framework can reduce long‑term operational costs. Organizations that leverage Imprivata’s national access modules can consolidate identity management, lower the administrative burden of dual credentials, and maintain compliance while modernising their IT stack. As funding pressures mount, the ability to protect patient data without disrupting care becomes a decisive competitive advantage for forward‑looking health providers.